4:53pm ET
Health and Healthcare
Is a Generic Nexium Purple Pill for You?
Teva Pharmaceutical announced on Monday that the FDA approved the first generic equivalent to Nexium delayed-release capsules in the United States.
Companies
/Healthcare
Astrazeneca plc
$162.70
▼ $1.82 (−1.11%) today
Markets closed · 6:19am ET
AZN Coverage
Page 101:30pm ET
Investing
Is Treasury Plan for Tax Inversion REALLY Trouble for Merger Stocks?
The U.S. Treasury has finally made its proposed effort to deal with the waves of corporate tax inversions that have created such a stir of late.
7:50am ET
Health and Healthcare
Drugmakers Merck, Pfizer Eke Out Profit Hikes
Drug giants Merck and Pfizer reported better-than-expected second-quarter 2014 results before markets opened Tuesday morning.
1:35pm ET
Health and Healthcare
Pfizer’s Real Issue: Identity Crisis Against Peers
Pfizer looks like it is out of the bid now for AstraZeneca. What looks increasingly obvious for a lackluster performance is that Pfizer may now simply be having an identity crisis.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: AMC, Cisco, NextEra, NRG, Staples and More
These are the top Wall Street analyst upgrades, downgrades and initiations seen after the three-day Memorial Day weekend. They include AMC, Cisco, NextEra, NRG and Staples.
3:11pm ET
Telecom & Wireless
Pfizer Rises, AT&T Sinks to Lead the Dow’s Action
ThinkstockBig news from two of the market’s biggest names is making waves across Wall Street today as stocks advance through a quiet start to the week. The Dow Jones Industrial Average (DJINDICES: ^DJI) has…
11:05am ET
Health and Healthcare
Cross-Border Premium Implications in Merck-Bayer Transaction
Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced that it had sold the business to Germany-based Bayer for $14.2 billion.
8:00am ET
Health and Healthcare
Pfizer Earnings Confirm Reasons for AstraZeneca Offer
Drug giant Pfizer reported better-than-expected first-quarter 2014 earnings before markets opened Monday morning, but revenues fell short. Shares traded lower in the premarket.
8:55am ET
Health and Healthcare
AstraZeneca Declares Pfizer Bid ‘Inadequate’
British drug maker AstraZeneca once again rejected a takeover bid from U.S. pharmaceutical giant Pfizer, this one worth $106 billion (about £50 a share) in cash and stock.
8:35am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, ARM, Barrick, Netflix, Teva, Valero and More
These are the top analyst upgrades, downgrades and initiations for Tuesday, April 22, 2014. They include AMD, ARM Holdings, Barrick Gold, Netflix, Teva Pharmaceutical and Valero Energy.
1:25pm ET
Health and Healthcare
What a Combined Pfizer and AstraZeneca Would Look Like, and Face
ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you hear of mergers in the $80 billion or $100 billion range? AstraZeneca…
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, MarkWest, NII Holdings, RF Micro, SodaStream and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, March 3, 2014. They include Apple, MarkWest Energy Partners, NII Holdings, RF Micro Devices and…
12:30pm ET
Health and Healthcare
Horizon Pharma Deal Ramps Up Profitability Timeline
ThinkstockHorizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with AstraZeneca PLC (NYSE: AZN) for the U.S. rights to VIMOVO. The move…
Jon C. Ogg 6:30am ET
Health and Healthcare
Big Pharma and 100,000 Jobs at Risk
ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company’s R&D operations. Since the return on research investment at Merck…
8:45am ET
Health and Healthcare
Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas
ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the top companies…
